of MEGX determination, by using NBD-F, which is highly reactive with primary as well as secondary amino groups [12] (the latter being found in MEGX). The reaction is simple, short (10 min), and does not require special conditions or equipment. The reaction product is stable for at least 2 days at 4°C in the dark, allowing repeat analyses within this period. The combination of a simple liquid-liquid extraction procedure with isocratic chromatography makes the method easy to perform in almost every laboratory. The internal standard MPGX can be readily synthesized, but as an alternative one can use the commercially available butanilicaine citrate (Hoechst AG, Frankfurt, Germany; data not shown). Use of the latter compound, however, increases the run time because of its later elution (ϳ18 min) from the column. If required, an even lower detection limit can be achieved by increasing the sample volume to 1 mL.
Since identification in 1989 of the gene responsible for cystic fibrosis (CF), the CF transmembrane conductance regulator (CFTR) [1] [2] [3] , Ͼ600 mutations have been identified [4] . Within the North American Caucasian population, 10 -12 mutations account for Ͼ80% of CF chromosomes [5] , this number varying somewhat according to ethnic origin. Within a diverse French Canadian population, three mutations, 621ϩ1G3 T (intron 4), A455E (exon 9), and 711ϩ1 G3 T (intron 5), are much more prevalent than in other ethnic groups, representing as much as 23% of the mutant chromosomes in some subpopulations [5] [6] [7] . The A455E mutation also represents 3% of all Dutch CF mutations [5] . In contrast, overall, these three mutations represent 0.7%, 0.1%, and 0.1%, respectively, of CF chromosomes [5] . DNA diagnostic laboratories often include these mutations in their analyses when searching for mutations within these specific ethnic groups.
The 621ϩ1G3 T CF mutation has been shown to produce a new HindII restriction site, which can be detected after gel electrophoresis of HindII-digested PCR products [6] . Detection of the A455E and 711ϩ1 G3 T mutations, however, has thus far generally been by the allele-specific oligonucleotide method [6 -9] , single-strand conformation polymorphism, or denaturing-gradient gel electrophoresis [10] . Allele-specific oligonucleotide assay, either normal or reverse dot-blot format, is a multistep, cumbersome technology, the commercially available forms of which do not assay the normal allele. As an alternative, we have developed a rapid and simple PCR restriction enzyme detection procedure, utilizing unique primers for the amplification of the A455E and 711ϩ1 G3 T regions of the CFTR gene on chromosome 7.
The PCR primers used to detect the A455E mutation are: forward, -5Ј-AGATAGAAAGAGGACAGTTGCT-3Ј (nucleotides 1472-1494), and reverse, -5Ј-GAACAAAA-GAACTACCTTGCCT-3Ј (nucleotides 1539 -1517). In the upstream primer, the C used in place of T is indicated here in underlined type. The C-to-A transversion produced by A455E at nucleotide 1496, 3-bp downstream of the forward primer, creates a new GsuI restriction site (5Ј-CTGGAG(N) 16 c-3Ј, the underlined A denoting the site of mutation) between nucleotides 1513 and 1514, in addition to the one ordinarily present between nucleotides 1531 and 1532, 7-bp from the 5Ј end of the reverse primer (see Fig. 1 ).
For 711ϩ1 G3 T, the sequences of the forward and reverse primers are respectively as follows: 5Ј-GCTGT-Clinical Chemistry 43, No. 6, 1997 CAAGCCGTGTTCTAG-3Ј (nucleotides 630 -649) and 5Ј-GCCTAAAAGATTAAATCAATAGGTACTTA-3Ј (nucleotides 741-713). The underlined T in the reverse primer marks replacement of the normal A. The G-to-T transversion produced by the 711ϩ1 G3 T mutation, 1-bp 5Ј to the reverse primer, creates a new MseI restriction site (TcTAT) (Fig. 1) .
"Hot-start" PCR was performed with a Perkin-Elmer Cetus (Mississauga, ON) Model 9600 thermal cycler after a 7-min denaturation at 94°C. The PCR used 300 ng of genomic DNA and 50 pmol of each primer in a final volume of 50 L; the buffer consisted of 10 mmol/L Tris-HCl (pH 8.8), 50 mmol/L KCl, 1.5 mmol/L MgCl 2 , 200 mol/L dNTPs, 5 mL/L Triton X, and 2.5 U of AmpliTaq (Perkin-Elmer Cetus). Amplification cycles (n ϭ 30) of 94°C for 30 s, 57°C (A455E) or 60°C (711ϩ1, G3 T) for 30 s, and 72°C for 1 min were followed by a 10-min elongation step at 72°C.
After the PCR, 15 L of PCR product was digested with GsuI (MBI Fermentas, Hamilton, ON) or MseI (New England Biolabs, Burlington, ON) as directed for 2 h at 37°C. Products were analyzed by electrophoresis on 12% polyacrylamide gel (PAGE). Aliquots of DNA isolated from carriers of the A455E and 711ϩ1G3 T mutations were a generous gift of Julian Zielenski, Department of Genetics, The Hospital for Sick Children, Toronto. DNA samples carrying no CF mutation were obtained from our laboratory collection.
The amplified PCR product obtained from nonmutant DNA with the A455E primers was 68 bp, and was cleaved to 61 and 7 bp by GsuI. In the presence of an A455E mutation, an extra restriction site was created, yielding restriction fragments of 42, 19, and 7 bp (Fig. 1) . Amplification of nonmutant DNA with the 711ϩ1 G3 T primers produced a fragment of 112 bp, cleaved by MseI to 99 and 13 bp. The new restriction site produced in the presence of a 711ϩ1 G3 T mutation resulted in fragments of 83, 16, and 13 bp ( Fig. 1 ). Heterozygote carriers of these mutations have a combination of normal and mutant patterns. Homozygous forms of these mutations are rarely found.
In conclusion, this design and use of "engineered" primers represent a rapid and efficient procedure for the analysis of the A455E and 711ϩ1G3 T CF mutations.
Assay of urinary iodine, along with other measurements, is essential for assessing the iodine status of populations in iodine-deficient areas and for monitoring the effectiveness of control programs. The International Council for Control of Iodine Deficiency Disorders has published a number of urinary iodine assays that are applicable to specific situations [1] . One commonly used method, their "Method A," is based on an initial mild chloric acid digestion to remove interfering substances, after which the iodine is quantified by its catalytic effect on reducing yellow ceric ion to colorless cerous ion in the presence of arsenious acid (Sandell-Kolthoff reaction). This is usually done manually in a colorimeter at 405 nm, the details having been described by Dunn et al. [2] . In brief, arsenious acid solution is added to each digested urine, blanks, and calibrators. After 15 min, ceric ammonium sulfate is added to each tube and all tubes are left at room temperature for exactly 20 min, at which time the remaining absorbance at 405 nm is measured.
In establishing this method in Hanoi, Vietnam, during the summer months, we consistently obtained very low absorbance readings for all tubes, including the blanks, and so made attempts to remove the supposed iodine 
